Dirui Industrial Co.,Ltd. (300396.SZ)
CNY 13.0
(1.17%)
CNY 13.0
(1.17%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 387.16 Million CNY | 11.4% |
| 2022 | 365.74 Million CNY | 33.19% |
| 2021 | 274.6 Million CNY | -3.99% |
| 2020 | 286.03 Million CNY | -18.46% |
| 2019 | 350.78 Million CNY | 2.7% |
| 2018 | 341.56 Million CNY | 4.65% |
| 2017 | 326.36 Million CNY | 2.18% |
| 2016 | 319.4 Million CNY | 39.38% |
| 2015 | 229.15 Million CNY | 28.0% |
| 2014 | 179.03 Million CNY | 13.04% |
| 2013 | 158.38 Million CNY | 14.13% |
| 2012 | 138.77 Million CNY | 30.42% |
| 2011 | 106.4 Million CNY | 53.48% |
| 2010 | 69.32 Million CNY | 27.2% |
| 2009 | 54.5 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 101.51 Million CNY | -11.83% |
| 2024 Q3 | 97.43 Million CNY | -1.31% |
| 2024 Q1 | 115.13 Million CNY | -23.68% |
| 2023 Q1 | 89.83 Million CNY | -26.12% |
| 2023 Q3 | 106.78 Million CNY | 18.66% |
| 2023 Q2 | 89.99 Million CNY | 0.17% |
| 2023 FY | 407.44 Million CNY | 11.4% |
| 2023 Q4 | 150.86 Million CNY | 41.27% |
| 2022 Q3 | 101.52 Million CNY | 19.44% |
| 2022 Q2 | 85 Million CNY | 47.53% |
| 2022 FY | 365.74 Million CNY | 33.19% |
| 2022 Q4 | 121.6 Million CNY | 19.77% |
| 2022 Q1 | 57.61 Million CNY | -29.81% |
| 2021 Q2 | 64.69 Million CNY | 22.63% |
| 2021 Q1 | 52.75 Million CNY | -25.01% |
| 2021 FY | 274.6 Million CNY | -3.99% |
| 2021 Q4 | 82.08 Million CNY | 9.33% |
| 2021 Q3 | 75.07 Million CNY | 16.06% |
| 2020 Q2 | 78.53 Million CNY | 19.22% |
| 2020 Q4 | 70.35 Million CNY | -1.28% |
| 2020 Q3 | 71.26 Million CNY | -9.27% |
| 2020 FY | 286.03 Million CNY | -18.46% |
| 2020 Q1 | 65.87 Million CNY | -41.69% |
| 2019 Q4 | 112.98 Million CNY | 39.59% |
| 2019 FY | 350.78 Million CNY | 2.7% |
| 2019 Q3 | 80.94 Million CNY | 12.18% |
| 2019 Q2 | 72.15 Million CNY | -14.8% |
| 2019 Q1 | 84.69 Million CNY | -26.72% |
| 2018 Q2 | 70.6 Million CNY | -0.15% |
| 2018 Q1 | 70.7 Million CNY | -35.2% |
| 2018 FY | 341.56 Million CNY | 4.65% |
| 2018 Q4 | 115.57 Million CNY | 36.49% |
| 2018 Q3 | 84.67 Million CNY | 19.92% |
| 2017 FY | 326.36 Million CNY | 2.18% |
| 2017 Q1 | 64.55 Million CNY | -43.89% |
| 2017 Q2 | 72.51 Million CNY | 12.33% |
| 2017 Q3 | 80.17 Million CNY | 10.56% |
| 2017 Q4 | 109.12 Million CNY | 36.11% |
| 2016 Q3 | 75.46 Million CNY | 6.69% |
| 2016 FY | 319.4 Million CNY | 39.38% |
| 2016 Q1 | 58.15 Million CNY | -32.18% |
| 2016 Q2 | 70.73 Million CNY | 21.63% |
| 2016 Q4 | 115.05 Million CNY | 52.46% |
| 2015 Q3 | 58.3 Million CNY | 38.43% |
| 2015 Q4 | 85.74 Million CNY | 47.07% |
| 2015 Q2 | 42.11 Million CNY | -2.02% |
| 2015 Q1 | 42.98 Million CNY | -30.66% |
| 2015 FY | 229.15 Million CNY | 28.0% |
| 2014 Q2 | 40 Million CNY | 17.0% |
| 2014 Q1 | 34.19 Million CNY | -22.9% |
| 2014 Q4 | 61.99 Million CNY | 44.68% |
| 2014 Q3 | 42.84 Million CNY | 7.11% |
| 2014 FY | 179.03 Million CNY | 13.04% |
| 2013 Q3 | 39.14 Million CNY | 0.0% |
| 2013 FY | 158.38 Million CNY | 14.13% |
| 2013 Q4 | 44.34 Million CNY | 13.28% |
| 2012 FY | 138.77 Million CNY | 30.42% |
| 2011 FY | 106.4 Million CNY | 53.48% |
| 2010 FY | 69.32 Million CNY | 27.2% |
| 2009 FY | 54.5 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 3.35 Billion CNY | 88.452% |
| Hangzhou Tigermed Consulting Co., Ltd. | 358.41 Million CNY | -8.021% |
| Beijing Strong Biotechnologies, Inc. | 702.74 Million CNY | 44.907% |
| Medicalsystem Biotechnology Co., Ltd. | 562.06 Million CNY | 31.117% |
| Maccura Biotechnology Co.Ltd | 1.18 Billion CNY | 67.201% |
| Guangzhou Wondfo Biotech Co.,Ltd | 1.17 Billion CNY | 67.061% |
| Guangdong Hybribio Biotech Co.,Ltd. | 631.43 Million CNY | 38.685% |
| BGI Genomics Co., Ltd. | 1.93 Billion CNY | 80.035% |
| Amoy Diagnostics Co., Ltd. | 574.96 Million CNY | 32.663% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 479.96 Million CNY | 19.336% |